Market Chatter: Organon Shares Rise Pre-Bell Amid Report of Sun Pharmaceutical's Proposed $13 Billion Bid

MT Newswires Live04-24 17:23

Organon (OGN) shares rose more than 7% in Friday's premarket activity amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.

Organon would merge with Sun Pharmaceutical if an agreement is reached, according to a report from the Economic Times. Sun Pharma is competing with other major players, the report added.

Organon and Sun Pharmaceutical did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 9.28, Change: +0.68, Percent Change: +7.89

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment